Huayu Yang Qing Ma Ying Sun Kan Zhang Yunli Xing Hongwei Li
10.3389/fonc.2022.1065137
Front Oncol
2022 Dec 22;12:1065137.
immune-related adverse events immunotherapy sintilimab thymic carcinoma toxic epidermal necrolysis
CC BY
https://pubmed.ncbi.nlm.nih.gov/36620577/
Case Reports
PMC9813861
36620577
Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma
2022